2021
DOI: 10.1016/j.pec.2021.02.044
|View full text |Cite
|
Sign up to set email alerts
|

How well do healthcare professionals know of the priorities of their older patients regarding treatment outcomes?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(15 citation statements)
references
References 25 publications
0
15
0
Order By: Relevance
“…In general, the representativeness of patients was good, although a few studies asked patients to provide answers for a hypothetical situation—for example, what they would choose if they had a different type or stage of cancer [ 29 , 40 ]. Some studies did not clearly report how specific outcomes were selected [ 28 , 29 ], or did not describe selection procedures at all [ 41 , 47 , 48 , 50 ]. Additionally, sometimes it was unclear how quality of life or other attributes were defined or were described to patients [ 27 , 39 ].…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…In general, the representativeness of patients was good, although a few studies asked patients to provide answers for a hypothetical situation—for example, what they would choose if they had a different type or stage of cancer [ 29 , 40 ]. Some studies did not clearly report how specific outcomes were selected [ 28 , 29 ], or did not describe selection procedures at all [ 41 , 47 , 48 , 50 ]. Additionally, sometimes it was unclear how quality of life or other attributes were defined or were described to patients [ 27 , 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…In a subgroup analysis of six studies focusing specifically on older patients [ 28 , 36 , 37 , 41 , 47 , 50 ] (median age of the study population of 70 years or higher or separate data of this subgroup), quality of life and overall survival were included in five of the six studies. They were also the highest or second-highest priority in most of them ( n = 5/6, 83%, and n = 4/6, 67%, respectively), followed by progression- and disease-free survival ( n = ½; 50%), severe and persistent side effects ( n = 1/3; 33%), treatment response ( n = 1/5; 20%), and transient short-term side effects ( n = 0/2; 0%; see Table 2 , Figure 4 ).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations